期刊文献+

射频热疗联合化疗对肺癌的疗效观察 被引量:4

射频热疗联合化疗对肺癌的疗效观察
下载PDF
导出
摘要 目的评价射频热疗联合化疗治疗肺癌的疗效,毒副反应及对生活质量的影响。方法 40例肺癌病人随机分为两组。治疗组20例采用射频热疗联合化疗药物,根据不同病种选择不同用药方案,TF,TB,CAP,NB。热疗5次/周,电脑实时测温温度控制在40℃~43℃,并维持45~60min。对照组20例采用化疗药物治疗,方法同治疗组。结果治疗组与对照组总有效率分别为75%和45%,两组比较差异有显著性(P<0.05);治疗组KPS评分与对照组比较差异有显著性(P<0.05)。急性毒性反应比较差异没有显著性,均可耐受。结论射频热疗联合化疗药物能显著提高肺癌的治疗效果,改善了病人的生存质量,是一种安全有效的方法 。 Objective Evaluate the rfheat treatment combination chemotherapy treatment of lung cancer therapeutic effect and adverse reaction of the quality of life and influence. Methods 40 patients with lung cancer patients were randomly divided into two groups. I ne treatment group 20 cases by the rf heat treatment combination chemotherapy drugs, according to different diseases choose different regimen, TC, TF, CAP, NB, heat therapy 5 times per week, the computer real-time temperature measuring temperature control in 40 ℃ - 43 ℃, and maintain 45 to 60 min. The control group 20 cases of chemotherapy drug therapy, methods and treatment group. ResuLts The treatment group and control group total effectiveness 75% and 45%, respectively, compared the two groups (P〈0.05); The treatment group KPS score compared with controls (P〈0.05). Acute toxicity reaction is no significant differences, all can tolerate.Gonclusion Rf heat treatment combination chemotherapy drugs can significantly improve the treatment effect of the lung cancer, to improve the life quality of patients, it is a safe and effective method.
出处 《当代医学》 2012年第24期47-48,共2页 Contemporary Medicine
关键词 射频热疗 化疗 肺癌 Rfheat treatment Lung cancer Chemotherapy
  • 相关文献

参考文献6

二级参考文献19

  • 1常恒,肖湘生,董伟华,李惠民,欧阳强,董生.动脉CT血管造影对肺转移瘤的血供研究[J].中华放射学杂志,2005,39(1):34-38. 被引量:32
  • 2陈雪琴,马胜林.肿瘤热疗作用机制研究进展[J].中华物理医学与康复杂志,2005,27(9):562-564. 被引量:23
  • 3虞喜豪,李新娉,周建梁,王建平,王革芳.腹腔化疗联合腹部透热全身热疗治疗恶性腹水的临床观察[J].临床内科杂志,2007,24(4):253-255. 被引量:9
  • 4马良俊.现代肿瘤内科手册[M].沈阳:辽宁科技出版社,1996:89.
  • 5Shimizu E,Na kamura Y,Mukai J,et al.Pharmacokinetics of bronchial artery infusion of mutomycin in patients with non-small cell lung cancer[J].Eur J Cancer,1991,27:1046.
  • 6Koljonen V,Tukiainen E,Haglund C,et al.Proliferative activity detected by Ki-67 correlates with poor outcome in merkel cell carcinoma[J].Histopathology,2006,49(5):551.
  • 7Dowsett M,Smith IE,Ebbs SB,et al.Prognostic value of Ki-67 expression after short-term presurgical endocrine therapy for primary breast cancer[J].J Natl Cancer Inst,2007,99(2):167.
  • 8Dowsett M,Smith IE.Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival[J].J Biol Chem,2004,279(52):54581.
  • 9Chami M,Prandini A,Campanella M,et al.Bcl-2 and bax exert opposing effects on Ca2+signaling,which do not depend on their putative pore forming region[J].Cell,1995,80(27):293-299.
  • 10Miyshita T,Keed JC.Tumor suppessor p53 is a direct transcriptional activator of the human bax gene[J].Cell,1995,80(27):293-299.

共引文献25

同被引文献29

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部